Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genetic Technologies (AU:GTG)
ASX:GTG
RESEARCH TOOLSreports
Genetic Technologies (GTG) Share Price & Analysis
1 Followers
GTG Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.09 - AU$0.20
Previous CloseAU$0.12
Volume20.00K
Average Volume (3M)77.09K
Market Cap
AU$15.87M
Enterprise ValueAU$8.53M
Total Cash (Recent Filing)AU$7.87M
Total Debt (Recent Filing)AU$532.85K
Price to Earnings (P/E)-1.0
Beta1.68
Next Earnings
Aug 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding1,154,166
10 Day Avg. Volume1,141,244
30 Day Avg. Volume77,087
Standard Deviation0.26
R-Squared0.07
Alpha-0.00718
Financial Highlights & Ratios
Price to Book (P/B)1.88
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genetic Technologies News
PremiumCompany Announcements
Genetic Technologies Sees Surge in Growth and Innovation
PremiumCompany Announcements
BNYMC Increases Stake in Genetic Technologies
PremiumCompany Announcements
Genetic Technologies Issues 43.2M Unquoted Warrants
PremiumCompany Announcements
Genetic Technologies Seeks New Stock QuotationPremiumCompany Announcements
Genetic Technologies Plans New Warrant Issue
PremiumCompany Announcements
Genetic Technologies Plans Major Securities IssueGTG FAQ
What was Genetic Technologies’s price range in the past 12 months?
Genetic Technologies lowest share price was AU$0.09 and its highest was AU$0.20 in the past 12 months.
What is Genetic Technologies’s market cap?
Currently, no data Available
When is Genetic Technologies’s upcoming earnings report date?
Genetic Technologies’s upcoming earnings report date is Aug 29, 2024 which is in 118 days.
How were Genetic Technologies’s earnings last quarter?
Genetic Technologies released its earnings results on Feb 23, 2024. The company reported -AU$0.056 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.056.
Is Genetic Technologies overvalued?
According to Wall Street analysts Genetic Technologies’s price is currently Overvalued.
Does Genetic Technologies pay dividends?
Genetic Technologies does not currently pay dividends.
What is Genetic Technologies’s EPS estimate?
Genetic Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genetic Technologies have?
Genetic Technologies has 132,217,240 shares outstanding.
What happened to Genetic Technologies’s price movement after its last earnings report?
Genetic Technologies reported an EPS of -AU$0.056 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genetic Technologies?
Currently, no hedge funds are holding shares in AU:GTG
---
Genetic Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:GTG Sentiment 66%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $52.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-156.80%
Trailing 12-Months
Asset Growth
-45.72%
Trailing 12-Months
Company Description
Genetic Technologies
Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
---
Technical Analysis
Genetic Technologies
―
Moleculin Biotech
―
Vericel
―
ADMA Biologics
―
Genetic Technologies
―
---